Lupin launches Prucalopride Tablets in the US market post FDA approval EP News Bureau Jun 26, 2025 Lupin begins US sales of Prucalopride Tablets, bioequivalent to Takeda’s Motegrity, for chronic idiopathic constipation treatment
